Skip to Content

Invokana

In the US, Invokana (canagliflozin systemic) is a member of the drug class SGLT-2 inhibitors and is used to treat Diabetes, Type 2.

US matches:

UK matches:

Ingredient matches for Invokana

Canagliflozin

Canagliflozin is reported as an ingredient of Invokana in the following countries:

  • Austria
  • Belgium
  • Canada
  • Croatia (Hrvatska)
  • Denmark
  • Poland
  • Romania
  • Singapore
  • Slovenia
  • United States

Canagliflozin hydrate (a derivative of Canagliflozin) is reported as an ingredient of Invokana in the following countries:

  • Chile
  • Germany
  • Ireland
  • Mexico
  • Sweden
  • Switzerland
  • United Kingdom

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide